Start Time: 16:30 January 1, 0000 5:29 PM ET

agilon health, inc. (NYSE:AGL)

Q3 2023 Earnings Conference Call

November 02, 2023, 16:30 PM ET

Company Participants

Steve Sell - CEO

Tim Bensley - CFO

Matthew Gillmor - VP, IR

Conference Call Participants

Lisa Gill - JPMorgan

Justin Lake - Wolfe Research

Stephen Baxter - Wells Fargo

Gary Taylor - Cowen

Jailendra Singh - Truist Securities

George Hill - Deutsche Bank

Whit Mayo - Leerink Partners

Adam Ron - Bank of America

Jamie Perse - Goldman Sachs

Elizabeth Anderson - Evercore ISI

Thomas Kelliher - RBC Capital Markets

Jack Wallace - Guggenheim

Operator

Hello, everyone. Welcome to the agilon health Third Quarter 2023 Earnings Conference Call. My name is Carla, and I will be your operator for today's call. Today's call will include a Q&A session. [Operator Instructions].

I would now hand you over to your host, Matthew Gillmor, Vice President of Investor Relations. Matthew, please go ahead.

Matthew Gillmor

Thanks, operator. Good afternoon and welcome to the call. With me is our CEO, Steve Sell; and our CFO, Tim Bensley.

Before we begin, we'd like to remind you that our remarks and responses to questions may include forward-looking statements. Actual results may differ materially from those stated or implied by forward-looking statements due to risks and uncertainties associated with our business. These risks and uncertainties are discussed in our SEC filings. Please note that we assume no obligation to update any forward-looking statements.

Additionally, certain financial measures we will discuss on this call are non-GAAP measures. We believe that providing these measures helps investors gain a better and more complete understanding of our financial results and is consistent with how management views our financial results. A reconciliation of these non-GAAP financial measures to the most comparable GAAP measure is available in the earnings press release and Form 8-K.

Following prepared remarks from Steve and Tim, we will conduct a Q&A session. During the Q&A session, we'd ask everyone to please limit themselves to one question so we can get through as many questions as possible.

With that, I'll turn things over to Steve.

Steve Sell

Thanks, Matt. Good evening and thank you for joining us. Momentum across our business remains strong, and we are making rapid progress against our vision, to transform healthcare in 100 plus communities by empowering primary care doctors. As an indicator of our success, this year we are on track to reinvest more than $250 million into local primary care based on the high quality, cost effective care being delivered by our partners.